Latest Views & News

This Niche Braincare Company could Profit from a Medical Boom

By Malcolm Stacey | Tuesday 19 July 2022


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Hello Share Spillers. A company with the rather clumsy name of Cambridge Cognition Holdings (COG) appears worth a look. It’s a niche medical outfit that assists in organising clinical trials for drugs and treatments. Since Covid, there’s a sharper focus on the medical sector and more money being spent on it.

You must be a registered member to read this story
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £5.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Tuesday »

SNX

Synectics – a recovery Buy?

 

GetAFix

Malcolm Stacey is Moving House

Monday »

WG

Wood Group - a Buy (again)?

 

Bear

Video: Bubbles always implode